CD274 and non-small cell lung carcinoma: To further characterize the relationships between co-occurring genomic alterations in detected gene modules and clinically important factors of NSCLC including histology and biomarkers of ICI response (TMB, PD-L1), we tested for dose-dependent associations between these factors and an increasing number of genomic alterations within a gene module (Figure 4; Supplementary Figure S2).